Home > Riviste > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Fascicoli precedenti > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 November;181(11) > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 November;181(11):847-54

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 November;181(11):847-54

DOI: 10.23736/S0393-3660.22.04810-0

Copyright © 2022 EDIZIONI MINERVA MEDICA

lingua: Inglese

Physiologic changes of serum creatinine level following aminoglycoside exposure in neonatal sepsis

Andi D. FEBRIANI , Andriana SUSANTI, Ema ALASIRY

Department of Pediatrics, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia



BACKGROUND: The study aimed to assess the pattern of serum creatinine levels changes and prevalence of AKI after aminoglycoside treatment for seven days in neonatal sepsis.
METHODS: This prospective cohort study included preterm and full-term newborns admitted with suspected sepsis and received aminoglycosides. SCr levels were measured before and after aminoglycoside treatment for seven days using the Jaffe method, and the results were compared between the two groups of newborns. AKI was determined according to the kidney disease: Improving Global Outcome (KDIGO) criteria.
RESULTS: A total of 37 preterm and 35 full-term newborns were included in the study. SCr levels before and after aminoglycoside treatment for seven days, were 0.78 vs. 0.57 mg/dL (P=0.008) in preterm, and 0.60 vs. 0.44 mg/dL (P=0.124) in full-term newborns. In both groups, SCr levels decreased despite treatment with an aminoglycoside, but only in preterm, the decrease was significant. After aminoglycoside treatment, there was no significant difference in SCr levels between the two groups. The prevalence of AKI in preterm and full-term newborns was 18.9% vs. 15.3% (P=0.598). There was no significant correlation between AKI and gestational age, chronological age, birth weight, type of aminoglycoside, and urine output.
CONCLUSIONS: SCr level changes after aminoglycoside treatment appear to follow a pattern of physiological decline and have not been affected by gestational age. AKI occurrence is a sign that aminoglycoside should be administered with caution, especially in newborns with high-risk underlying diseases.


KEY WORDS: Aminoglycosides; Creatinine; Infant, newborn

inizio pagina